Peptide Therapy for Peak Performance
Information about peptide therapies, what the research does and does not show, and how a licensed provider evaluates whether a discussion is appropriate for you.
20+
Peptide Protocols
Research
Study-Informed
Custom
Personalized Rx
Precision
Targeted Protocols
Naturally Occurring
Peptides are short amino acid chains that occur naturally in the body. Therapeutic peptides mimic or amplify these natural signaling molecules.
Highly Targeted
Peptides act on specific receptors, which is why research interest in them has focused on targeted signaling rather than broad-spectrum activity.
Research Context
Peptides have been studied in research settings for decades, but study quality varies widely and most of the peptides described below are not FDA-approved for the uses discussed. Research interest is not the same as regulatory approval.
Available Peptide Therapies
The following are described for information only. A licensed provider determines whether any discussion of these substances is medically appropriate for you.
BPC-157
A synthetic peptide derived from a protein found in gastric juice. BPC-157 is not FDA-approved, has been studied largely in preclinical and animal models, and its regulatory status for compounding is under active FDA review and may change.
- Not FDA-approved
- Studied in preclinical models
- Regulatory status under review
- Provider evaluation required
Sermorelin / CJC-1295
Growth hormone-releasing peptides studied for their effect on pituitary signaling. Compounded formulations of these peptides are not FDA-approved products, and their long-term effects have not been established.
- Not an FDA-approved product
- Studied for GH signaling
- Long-term effects unestablished
- Provider evaluation required
Ipamorelin
A selective growth hormone secretagogue studied for its effect on GH release. Ipamorelin is not FDA-approved for any indication, and its safety and effectiveness have not been established through FDA review.
- Not FDA-approved
- Selective GH secretagogue
- Effects not established
- Provider evaluation required
AOD-9604
A modified fragment of human growth hormone that has been studied for its role in fat metabolism. AOD-9604 is not FDA-approved for any indication, and its long-term safety and effectiveness have not been established.
- Not FDA-approved
- Studied for fat metabolism
- Long-term safety unestablished
- Provider evaluation required
PT-141 (Bremelanotide)
A melanocortin receptor agonist that acts on central pathways involved in sexual desire. Bremelanotide is FDA-approved under the brand name Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women only. It is not FDA-approved for use in men, and compounded bremelanotide is not an FDA-approved product.
- Approved indication: HSDD
- Premenopausal women only
- Not approved for men
- Provider evaluation required
Thymosin Alpha-1
A naturally occurring peptide studied for its role in immune signaling. Thymosin Alpha-1 is not FDA-approved for any indication in the United States and is not offered to treat, cure, or prevent any disease or infection.
- Not FDA-approved
- Studied for immune signaling
- Not for treating disease
- Provider evaluation required
Frequently Asked Questions
Peptides are short chains of amino acids that act as signaling molecules in the body. They regulate a wide range of biological functions including hormone production, immune response, tissue repair, and metabolism. Therapeutic peptides are used to amplify or restore these natural processes.
Safety varies by peptide and by individual. Most of the peptides described on this page are not FDA-approved, which means their safety and effectiveness have not been established through the FDA review process. A licensed provider will review your health history and discuss known risks, unknowns, and alternatives with you before anything is prescribed.
Most therapeutic peptides are administered via subcutaneous injection using very small insulin-style needles. Some are available as nasal sprays or oral formulations. Your provider will walk you through the administration process.
There is no established timeline. Because most of these peptides are not FDA-approved, there is no reviewed evidence base supporting a predictable onset or outcome, and any individual response is determined by your provider's clinical judgment and your own health context.
Have Questions Worth Asking a Clinician?
Consult with a licensed provider to discuss whether any of this is relevant to your health context.
Get StartedImportant regulatory information. Except where a specific FDA-approved brand-name product is identified above, the substances described on this page are not approved by the U.S. Food and Drug Administration for the uses discussed. Compounded medications are not FDA-approved products. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Availability of any compounded substance is subject to change based on FDA action.